首页 > 最新文献

Journal of Epidemiology最新文献

英文 中文
Erratum: "Coffee and Green Tea Consumption With the Risk of COVID-19 Among the Vaccine Recipients in Japan: A Prospective Study" [J Epidemiol 34(9) (2024) 444-452]. 更正:“日本疫苗接种者饮用咖啡和绿茶与COVID-19风险的前瞻性研究”[J].流行病学杂志,34(9)(2024)444-452。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-12-05 Epub Date: 2025-10-31 DOI: 10.2188/jea.JE20250309
Zobida Islam, Shohei Yamamoto, Tetsuya Mizoue, Maki Konishi, Norio Ohmagari
{"title":"Erratum: \"Coffee and Green Tea Consumption With the Risk of COVID-19 Among the Vaccine Recipients in Japan: A Prospective Study\" [J Epidemiol 34(9) (2024) 444-452].","authors":"Zobida Islam, Shohei Yamamoto, Tetsuya Mizoue, Maki Konishi, Norio Ohmagari","doi":"10.2188/jea.JE20250309","DOIUrl":"10.2188/jea.JE20250309","url":null,"abstract":"","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":"521"},"PeriodicalIF":3.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12620548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144575584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Body Mass Index and Head and Neck Cancer Risk. 身体质量指数与头颈癌风险
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-12-05 Epub Date: 2025-10-31 DOI: 10.2188/jea.JE20250218
Shih-Wei Lai, Kuan-Fu Liao
{"title":"Body Mass Index and Head and Neck Cancer Risk.","authors":"Shih-Wei Lai, Kuan-Fu Liao","doi":"10.2188/jea.JE20250218","DOIUrl":"10.2188/jea.JE20250218","url":null,"abstract":"","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":"518"},"PeriodicalIF":3.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12620550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter "Body Mass Index, Height, and Head and Neck Cancer Risk: The Japan Public Health Center-based Prospective Study". 对“身体质量指数、身高和头颈癌风险:基于日本公共卫生中心的前瞻性研究”信函的回应。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-12-05 Epub Date: 2025-10-31 DOI: 10.2188/jea.JE20250399
Norie Sawada, Tomohiro Shinozaki, Seitaro Suzuki, Taiki Yamaji, Motoki Iwasaki, Manami Inoue, Shoichiro Tsugane
{"title":"Response to the Letter \"Body Mass Index, Height, and Head and Neck Cancer Risk: The Japan Public Health Center-based Prospective Study\".","authors":"Norie Sawada, Tomohiro Shinozaki, Seitaro Suzuki, Taiki Yamaji, Motoki Iwasaki, Manami Inoue, Shoichiro Tsugane","doi":"10.2188/jea.JE20250399","DOIUrl":"10.2188/jea.JE20250399","url":null,"abstract":"","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":"519-520"},"PeriodicalIF":3.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12620552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145232655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cohort Profile: Shanghai University of Sport (SUS) Longitudinal Cohort Study of Alumni Health Tracking. 队列简介:上海体育大学校友健康追踪纵向队列研究。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-22 DOI: 10.2188/jea.JE20240494
Huanyu Wang, Ruwen Wang, Qin Sun, Shanshan Guo, Kaiqing Lin, Qianqian Tian, Keneilwe Kenny Kaudimba, Mingjia Yang, Tiemin Liu, Ru Wang

BackgroundThe Shanghai University of Sport (SUS) Longitudinal Cohort Study (SUS Cohort) was established to investigate the influence of lifestyle and modifiable behavioural factors in early adulthood on the development of non-communicable diseases (NCDs) later in life. The cohort aims to identify novel biomarkers and explore mechanisms underlying chronic diseases using a multi-omics approach.MethodsThe SUS Cohort study is a prospective cohort study of undergraduate students between 2018 and 2019, with follow-ups conducted every two years during early adulthood and every ten years thereafter. Comprehensive data collection includes body composition measurements, lifestyle surveys, physical fitness tests, and clinical laboratory tests. Multi-omics analysis, including genome-wide genotyping, gut microbiome and serum metabolome, is integrated to provide insights into disease pathophysiology.ResultsA total of 1,758 participants aged 18 to 22(mean age: 18.64 ± 3.15) were conducted from baseline surveys, with a follow-up period between September 2021 and September 2022. The median age at baseline was 18 years, and the proportion of female participants was about 871(49.5%). Of the initial participants, 1,055 individuals (60%) completed the follow-up.ConclusionThe SUS Cohort provides multidimensional data to study how early-life factors influence long-term health outcomes.

背景上海体育学院(SUS)纵向队列研究(SUS队列)旨在探讨成年早期的生活方式和可改变的行为因素对以后生活中非传染性疾病(ncd)发展的影响。该队列旨在使用多组学方法识别新的生物标志物并探索慢性疾病的机制。SUS队列研究是一项针对2018年至2019年本科生的前瞻性队列研究,在成年早期每两年进行一次随访,此后每十年进行一次随访。全面的数据收集包括身体成分测量、生活方式调查、体能测试和临床实验室测试。整合多组学分析,包括全基因组基因分型,肠道微生物组和血清代谢组,以提供对疾病病理生理学的见解。结果基线调查共纳入1758名18 ~ 22岁的参与者(平均年龄:18.64±3.15岁),随访时间为2021年9月至2022年9月。基线时中位年龄为18岁,女性参与者比例约为871人(49.5%)。在最初的参与者中,1055人(60%)完成了随访。结论SUS队列为研究早期生活因素如何影响长期健康结果提供了多维数据。
{"title":"Cohort Profile: Shanghai University of Sport (SUS) Longitudinal Cohort Study of Alumni Health Tracking.","authors":"Huanyu Wang, Ruwen Wang, Qin Sun, Shanshan Guo, Kaiqing Lin, Qianqian Tian, Keneilwe Kenny Kaudimba, Mingjia Yang, Tiemin Liu, Ru Wang","doi":"10.2188/jea.JE20240494","DOIUrl":"https://doi.org/10.2188/jea.JE20240494","url":null,"abstract":"<p><p>BackgroundThe Shanghai University of Sport (SUS) Longitudinal Cohort Study (SUS Cohort) was established to investigate the influence of lifestyle and modifiable behavioural factors in early adulthood on the development of non-communicable diseases (NCDs) later in life. The cohort aims to identify novel biomarkers and explore mechanisms underlying chronic diseases using a multi-omics approach.MethodsThe SUS Cohort study is a prospective cohort study of undergraduate students between 2018 and 2019, with follow-ups conducted every two years during early adulthood and every ten years thereafter. Comprehensive data collection includes body composition measurements, lifestyle surveys, physical fitness tests, and clinical laboratory tests. Multi-omics analysis, including genome-wide genotyping, gut microbiome and serum metabolome, is integrated to provide insights into disease pathophysiology.ResultsA total of 1,758 participants aged 18 to 22(mean age: 18.64 ± 3.15) were conducted from baseline surveys, with a follow-up period between September 2021 and September 2022. The median age at baseline was 18 years, and the proportion of female participants was about 871(49.5%). Of the initial participants, 1,055 individuals (60%) completed the follow-up.ConclusionThe SUS Cohort provides multidimensional data to study how early-life factors influence long-term health outcomes.</p>","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Financial Performance of Medical Corporations in Japan from 2016 to 2022: A Nationwide Longitudinal Analysis. 2016 - 2022年日本医疗企业财务绩效的纵向分析
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-22 DOI: 10.2188/jea.JE20250303
Satoshi Funada, Shusuke Hiragi, Michiko Ashizawa, Rei Goto

BackgroundMedical corporations (Iryohoujin) are central to Japan's healthcare delivery, yet their financial conditions have not been comprehensively assessed nationwide. This study aimed to describe financial trends and structural characteristics of hospital-operating corporations from fiscal year (FY) 2016 to FY2022 and examine fluctuations, including during the FY2020-FY2021 COVID-19 pandemic.MethodsA longitudinal analysis was conducted using financial data covering 95% of all hospital-operating medical corporations. Financial indicators, including total assets, medical revenue, and profit margin, were tracked from FY2016 to FY2022. Subgroup analyses were based on organizational size and integration. A linear mixed-effects model examined factors associated with profitability.ResultsThe number of hospital-operating medical corporations declined from 4,631 in FY2016 to 4,469 in FY2022. By FY2022, total assets and medical revenue reached 15.9 trillion JPY and 12.5 trillion JPY. Median medical profit margin declined from 1.8% (interquartile range [IQR], -1.2% to 5.3%) in FY2016 to 0.6% (IQR, -3.4% to 4.3%) in FY2021, then recovered to 1.6% (IQR, -2.5% to 5.5%) in FY2022. Smaller corporations, with fewer hospitals and beds, were more financially unstable, especially during the COVID-19 pandemic. A linear mixed-effects model showed that medical profit margin was negatively associated with hospital number and positively associated with long-term care and psychiatric beds.ConclusionsThis study highlights the structural scale and financial dynamics of Japanese medical corporations, revealing a large but unevenly resilient sector in which not only hospital size but also bed composition significantly influences profitability. These findings may inform policy discussions on healthcare system sustainability and financial support.

医疗公司(Iryohoujin)是日本医疗保健服务的核心,但其财务状况尚未在全国范围内进行全面评估。本研究旨在描述2016财年至2022财年医院运营公司的财务趋势和结构特征,并检查波动,包括2020财年至2021财年COVID-19大流行期间。方法利用95%的医院经营医疗企业财务数据进行纵向分析。财务指标,包括总资产、医疗收入和利润率,从2016财年跟踪到2022财年。亚组分析基于组织规模和整合。线性混合效应模型考察了与盈利能力相关的因素。结果医院经营医疗企业数量从2016财年的4631家下降到2022财年的4469家。到2022财年,总资产和医疗收入分别达到15.9万亿日元和12.5万亿日元。医疗利润率中位数从2016财年的1.8%(四分位数区间[IQR], -1.2%至5.3%)下降至2021财年的0.6% (IQR, -3.4%至4.3%),然后在2022财年回升至1.6% (IQR, -2.5%至5.5%)。医院和床位较少的小公司在财务上更不稳定,尤其是在COVID-19大流行期间。线性混合效应模型显示,医疗利润率与医院数量呈负相关,与长期护理和精神科床位呈正相关。本研究强调了日本医疗企业的结构规模和财务动态,揭示了一个庞大但弹性不均匀的行业,其中医院规模和床位构成不仅对盈利能力有显著影响。这些发现可以为卫生保健系统可持续性和财政支持的政策讨论提供信息。
{"title":"Financial Performance of Medical Corporations in Japan from 2016 to 2022: A Nationwide Longitudinal Analysis.","authors":"Satoshi Funada, Shusuke Hiragi, Michiko Ashizawa, Rei Goto","doi":"10.2188/jea.JE20250303","DOIUrl":"https://doi.org/10.2188/jea.JE20250303","url":null,"abstract":"<p><p>BackgroundMedical corporations (Iryohoujin) are central to Japan's healthcare delivery, yet their financial conditions have not been comprehensively assessed nationwide. This study aimed to describe financial trends and structural characteristics of hospital-operating corporations from fiscal year (FY) 2016 to FY2022 and examine fluctuations, including during the FY2020-FY2021 COVID-19 pandemic.MethodsA longitudinal analysis was conducted using financial data covering 95% of all hospital-operating medical corporations. Financial indicators, including total assets, medical revenue, and profit margin, were tracked from FY2016 to FY2022. Subgroup analyses were based on organizational size and integration. A linear mixed-effects model examined factors associated with profitability.ResultsThe number of hospital-operating medical corporations declined from 4,631 in FY2016 to 4,469 in FY2022. By FY2022, total assets and medical revenue reached 15.9 trillion JPY and 12.5 trillion JPY. Median medical profit margin declined from 1.8% (interquartile range [IQR], -1.2% to 5.3%) in FY2016 to 0.6% (IQR, -3.4% to 4.3%) in FY2021, then recovered to 1.6% (IQR, -2.5% to 5.5%) in FY2022. Smaller corporations, with fewer hospitals and beds, were more financially unstable, especially during the COVID-19 pandemic. A linear mixed-effects model showed that medical profit margin was negatively associated with hospital number and positively associated with long-term care and psychiatric beds.ConclusionsThis study highlights the structural scale and financial dynamics of Japanese medical corporations, revealing a large but unevenly resilient sector in which not only hospital size but also bed composition significantly influences profitability. These findings may inform policy discussions on healthcare system sustainability and financial support.</p>","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of recorded diagnoses of acute kidney injury among surgical patients in the Japanese Diagnosis Procedure Combination database. 日本诊断程序组合数据库中外科患者急性肾损伤记录诊断的验证。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-22 DOI: 10.2188/jea.JE20250387
So Sato, Akira Okada, Yoshihisa Miyamoto, Hayato Yamana, Hideo Yasunaga

Background: Researchers widely use the Diagnosis Procedure Combination (DPC) database for studies on acute-care hospitalization in Japan. However, the validity of acute kidney injury (AKI) diagnostic codes among patients who underwent surgery under general anesthesia is unclear.

Methods: Under the Japanese Next-Generation Healthcare Infrastructure Act, we obtained DPC data linked with the laboratory data of adult surgical patients with baseline and follow-up serum creatinine measurements from three hospitals (2021- 2024). Recorded diagnoses of AKI were identified using the International Classification of Diseases-10th Revision codes (N17.x). The reference standard was the diagnosis of AKI per the creatinine-based Kidney Disease: Improving Global Outcomes (KDIGO) criteria. The sensitivity, specificity, likelihood ratios, and predictive values were calculated. We evaluated the coding validity for identifying AKI stages 2 and 3. Subgroup analyses were conducted according to baseline estimated glomerular filtration rates (eGFR) (≥60.0, 30.0-59.9, 15.0-29.9 mL/min/1.73 m2), type of admission (planned/emergent), and surgery type (cardiovascular/non-cardiovascular).

Results: Among 7,374 eligible patients, 663 (9.0%) met the KDIGO-defined AKI criteria, while 35 (0.5%) patients had the AKI codes. The sensitivity was 4.1% (95% CI, 2.7-5.9%), and specificity was 99.9% (95% CI, 99.8-99.9%). The sensitivity increased for patients with stages 2 and 3 AKI, lower eGFR, emergent admission, or cardiovascular surgery.

Conclusions: Among surgical patients, AKI coding in the DPC exhibited high specificity and positive predictive value, albeit low sensitivity. Incorporating laboratory data is important for more accurate identification of patients with AKI for use in clinical studies.

背景:日本研究人员广泛使用诊断程序组合(DPC)数据库进行急性护理住院研究。然而,急性肾损伤(AKI)诊断代码在全麻手术患者中的有效性尚不清楚。方法:根据日本下一代医疗基础设施法案,我们从三家医院(2021- 2024)获得了与基线和随访血清肌酐测量的成年外科患者实验室数据相关的DPC数据。记录的AKI诊断使用国际疾病分类第十次修订代码(N17.x)进行鉴定。参考标准是根据基于肌酐的肾脏疾病:改善全球结局(KDIGO)标准诊断AKI。计算敏感性、特异性、似然比和预测值。我们评估了识别AKI 2期和3期的编码有效性。根据基线估计肾小球滤过率(eGFR)(≥60.0、30.0-59.9、15.0-29.9 mL/min/1.73 m2)、入院类型(计划/紧急)和手术类型(心血管/非心血管)进行亚组分析。结果:在7374例符合条件的患者中,663例(9.0%)符合kdigo定义的AKI标准,而35例(0.5%)患者具有AKI代码。敏感性为4.1% (95% CI, 2.7 ~ 5.9%),特异性为99.9% (95% CI, 99.8 ~ 99.9%)。对于2期和3期AKI、eGFR较低、紧急入院或心血管手术的患者,敏感性增加。结论:在手术患者中,AKI编码在DPC中表现出高特异性和阳性预测价值,尽管敏感性较低。结合实验室数据对于更准确地识别AKI患者用于临床研究是很重要的。
{"title":"Validation of recorded diagnoses of acute kidney injury among surgical patients in the Japanese Diagnosis Procedure Combination database.","authors":"So Sato, Akira Okada, Yoshihisa Miyamoto, Hayato Yamana, Hideo Yasunaga","doi":"10.2188/jea.JE20250387","DOIUrl":"https://doi.org/10.2188/jea.JE20250387","url":null,"abstract":"<p><strong>Background: </strong>Researchers widely use the Diagnosis Procedure Combination (DPC) database for studies on acute-care hospitalization in Japan. However, the validity of acute kidney injury (AKI) diagnostic codes among patients who underwent surgery under general anesthesia is unclear.</p><p><strong>Methods: </strong>Under the Japanese Next-Generation Healthcare Infrastructure Act, we obtained DPC data linked with the laboratory data of adult surgical patients with baseline and follow-up serum creatinine measurements from three hospitals (2021- 2024). Recorded diagnoses of AKI were identified using the International Classification of Diseases-10<sup>th</sup> Revision codes (N17.x). The reference standard was the diagnosis of AKI per the creatinine-based Kidney Disease: Improving Global Outcomes (KDIGO) criteria. The sensitivity, specificity, likelihood ratios, and predictive values were calculated. We evaluated the coding validity for identifying AKI stages 2 and 3. Subgroup analyses were conducted according to baseline estimated glomerular filtration rates (eGFR) (≥60.0, 30.0-59.9, 15.0-29.9 mL/min/1.73 m<sup>2</sup>), type of admission (planned/emergent), and surgery type (cardiovascular/non-cardiovascular).</p><p><strong>Results: </strong>Among 7,374 eligible patients, 663 (9.0%) met the KDIGO-defined AKI criteria, while 35 (0.5%) patients had the AKI codes. The sensitivity was 4.1% (95% CI, 2.7-5.9%), and specificity was 99.9% (95% CI, 99.8-99.9%). The sensitivity increased for patients with stages 2 and 3 AKI, lower eGFR, emergent admission, or cardiovascular surgery.</p><p><strong>Conclusions: </strong>Among surgical patients, AKI coding in the DPC exhibited high specificity and positive predictive value, albeit low sensitivity. Incorporating laboratory data is important for more accurate identification of patients with AKI for use in clinical studies.</p>","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and Clinical Outcomes of Meningococcal Infections in Japan: A Nationwide Inpatient Database Study from 2010 to 2023. 日本脑膜炎球菌感染的流行病学和临床结果:2010 - 2023年全国住院患者数据库研究
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-08 DOI: 10.2188/jea.JE20250229
Satoshi Kutsuna, Hiroyuki Ohbe, Yuya Kimura, Shuhei Yokoyama, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

Background: Meningococcal infection remains a life-threatening disease despite advances in early recognition and therapy. While the incidence of meningococcal infection is extremely low in Japan, nationwide data on its clinical outcomes have been lacking.

Methods: We conducted a retrospective cohort study using the Japanese Diagnosis Procedure Combination (DPC) inpatient database from July 2010 to March 2023. Patients with a main diagnosis of meningococcal infection (ICD-10 code A39) were included. The primary outcome was in-hospital mortality. Secondary outcomes included impaired consciousness at discharge and functional status, assessed by the Barthel Index. Multivariable logistic regression was performed to identify prognostic factors.

Results: A total of 465 patients were analyzed. The median age was 55 years, and 57.0% were male. The in-hospital mortality rate was 8.2%, and 40.2% of survivors had a Barthel Index ≤90 at discharge. Early antibiotic administration did not significantly reduce mortality but was associated with improved neurological outcomes. Baseline impaired consciousness was the strongest predictor of mortality and poor functional status, while chronic comorbidities also contributed to worse outcomes. Notably, older age itself was not independently associated with mortality after adjustment for severity and comorbidities.

Conclusion: Meningococcal infection outcomes in Japan are predominantly determined by the severity of illness at presentation and comorbid health conditions rather than age alone. Early antibiotic therapy improves neurological recovery but may not prevent death once critical illness is established. These findings underscore the importance of prevention through vaccination and early recognition strategies to reduce the burden of this devastating infection.

背景:尽管在早期识别和治疗方面取得了进展,但脑膜炎球菌感染仍然是一种危及生命的疾病。虽然日本脑膜炎球菌感染的发病率极低,但缺乏关于其临床结果的全国数据。方法:2010年7月至2023年3月,使用日本诊断程序组合(DPC)住院患者数据库进行回顾性队列研究。包括主要诊断为脑膜炎球菌感染(ICD-10代码A39)的患者。主要终点是住院死亡率。次要结局包括出院时意识受损和功能状态,以Barthel指数评估。采用多变量logistic回归来确定预后因素。结果:共分析465例患者。中位年龄55岁,男性占57.0%。住院死亡率为8.2%,出院时Barthel指数≤90的幸存者占40.2%。早期抗生素治疗没有显著降低死亡率,但与改善神经预后相关。基线意识受损是死亡率和功能状态差的最强预测因子,而慢性合并症也会导致更差的结果。值得注意的是,在调整严重程度和合并症后,年龄本身与死亡率没有独立的相关性。结论:在日本,脑膜炎球菌感染的结果主要取决于疾病的严重程度和合并症的健康状况,而不仅仅是年龄。早期抗生素治疗可以改善神经系统的恢复,但可能无法预防重症患者的死亡。这些发现强调了通过疫苗接种和早期识别战略进行预防以减轻这种破坏性感染负担的重要性。
{"title":"Epidemiology and Clinical Outcomes of Meningococcal Infections in Japan: A Nationwide Inpatient Database Study from 2010 to 2023.","authors":"Satoshi Kutsuna, Hiroyuki Ohbe, Yuya Kimura, Shuhei Yokoyama, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga","doi":"10.2188/jea.JE20250229","DOIUrl":"https://doi.org/10.2188/jea.JE20250229","url":null,"abstract":"<p><strong>Background: </strong>Meningococcal infection remains a life-threatening disease despite advances in early recognition and therapy. While the incidence of meningococcal infection is extremely low in Japan, nationwide data on its clinical outcomes have been lacking.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using the Japanese Diagnosis Procedure Combination (DPC) inpatient database from July 2010 to March 2023. Patients with a main diagnosis of meningococcal infection (ICD-10 code A39) were included. The primary outcome was in-hospital mortality. Secondary outcomes included impaired consciousness at discharge and functional status, assessed by the Barthel Index. Multivariable logistic regression was performed to identify prognostic factors.</p><p><strong>Results: </strong>A total of 465 patients were analyzed. The median age was 55 years, and 57.0% were male. The in-hospital mortality rate was 8.2%, and 40.2% of survivors had a Barthel Index ≤90 at discharge. Early antibiotic administration did not significantly reduce mortality but was associated with improved neurological outcomes. Baseline impaired consciousness was the strongest predictor of mortality and poor functional status, while chronic comorbidities also contributed to worse outcomes. Notably, older age itself was not independently associated with mortality after adjustment for severity and comorbidities.</p><p><strong>Conclusion: </strong>Meningococcal infection outcomes in Japan are predominantly determined by the severity of illness at presentation and comorbid health conditions rather than age alone. Early antibiotic therapy improves neurological recovery but may not prevent death once critical illness is established. These findings underscore the importance of prevention through vaccination and early recognition strategies to reduce the burden of this devastating infection.</p>","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing life-course analyses of financial disadvantage and depressive mood through longitudinal design and causal inference. 通过纵向设计和因果推理加强经济劣势与抑郁情绪的生命历程分析。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-08 DOI: 10.2188/jea.JE20250542
Quan Zhang
{"title":"Enhancing life-course analyses of financial disadvantage and depressive mood through longitudinal design and causal inference.","authors":"Quan Zhang","doi":"10.2188/jea.JE20250542","DOIUrl":"https://doi.org/10.2188/jea.JE20250542","url":null,"abstract":"","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproducibility of Age at Menarche Gathered From Mail Questionnaires: A Report From the Life Span Study. 从邮件问卷中收集的初潮年龄的可重复性:一份来自寿命研究的报告。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-05 Epub Date: 2025-09-30 DOI: 10.2188/jea.JE20250027
Yuko Kadowaki, Alina V Brenner, Michiko Yamada, Hiromi Sugiyama, Mai Utada, Munechika Misumi, Ritsu Sakata

Background: Menarche timing may affect female health. While previous studies evaluated self-reported age at menarche reproducibility, they did not assess types of respondents. This study compared the reproducibility of age at menarche among self-responders and proxy respondents and assessed proxy-respondent reproducibility by relationship and survey age.

Methods: Data on age at menarche reported in both the 1969 and 1978 mail questionnaires among 9,043 females from the Life Span Study cohort of atomic bomb survivors were analyzed. The reproducibility of menarcheal age was assessed by the type of respondents, by proxy's relationship to participant, and by age at the 1969 survey using Bland-Altman's method and the intraclass correlation coefficient (ICC).

Results: Reproducibility was moderate (95% limits of agreement, -2.3 to 2.4 years; ICC 0.72; 95% confidence interval, 0.71-0.73). Both self-respondents (N = 6,664) and the total study population (N = 9,043) maintained moderate reproducibility even at older ages. Groups with proxy reports showed lower reproducibility than self-respondents, with spouse proxy reports showing highest reproducibility and parent proxy reports showing lowest reproducibility among proxy reports, although the comparisons are based on different survey ages in 1969.

Conclusion: This is the first study to evaluate menarcheal-age reproducibility between self- and proxy-reports using appropriate measures. Mail questionnaires at 9-year interval showed moderate reproducibility across all ages, including elderly self-respondents. Reproducibility varied by the respondent-target relationship, with spouse proxies showing highest and parent proxies showing lowest reproducibility among proxy reports. Additional data are required to establish appropriate methods for handling specific proxy responses.

背景:月经初潮时间可能影响女性健康。虽然以前的研究评估了初潮时自我报告的年龄可重复性,但他们没有评估被调查者的类型。本研究比较了自我应答者和代理应答者初月经年龄的可重复性,并通过关系和调查年龄来评估代理应答者的可重复性。方法:对1969年和1978年“原子弹幸存者寿命研究”队列中9043名女性的邮件调查问卷中有关月经初潮年龄的数据进行分析。采用Bland-Altman方法和类内相关系数(ICC),通过被调查者的类型、代理人与参与者的关系以及1969年调查时的年龄来评估初月经年龄的可重复性。结果:重复性为中等(95%一致限:-2.3 ~ 2.4年;Icc: 0.72, 95% ci, 0.71-0.73)。自我调查对象(N=6,664)和总研究人群(N=9,043)即使在老年人中也保持适度的可重复性。尽管比较是基于1969年不同的调查年龄,但代理报告中配偶代理报告的可重复性最高,父母代理报告的可重复性最低。结论:这是第一个用适当的方法评估自我报告和代理报告的月经初潮年龄可重复性的研究。9年的邮件问卷调查在所有年龄段都显示出适度的再现性,包括老年人的自我调查者。可重复性因受访者-目标关系而异,在代理报告中,配偶代理的可重复性最高,而父母代理的可重复性最低。需要额外的数据来建立处理特定代理响应的适当方法。
{"title":"Reproducibility of Age at Menarche Gathered From Mail Questionnaires: A Report From the Life Span Study.","authors":"Yuko Kadowaki, Alina V Brenner, Michiko Yamada, Hiromi Sugiyama, Mai Utada, Munechika Misumi, Ritsu Sakata","doi":"10.2188/jea.JE20250027","DOIUrl":"10.2188/jea.JE20250027","url":null,"abstract":"<p><strong>Background: </strong>Menarche timing may affect female health. While previous studies evaluated self-reported age at menarche reproducibility, they did not assess types of respondents. This study compared the reproducibility of age at menarche among self-responders and proxy respondents and assessed proxy-respondent reproducibility by relationship and survey age.</p><p><strong>Methods: </strong>Data on age at menarche reported in both the 1969 and 1978 mail questionnaires among 9,043 females from the Life Span Study cohort of atomic bomb survivors were analyzed. The reproducibility of menarcheal age was assessed by the type of respondents, by proxy's relationship to participant, and by age at the 1969 survey using Bland-Altman's method and the intraclass correlation coefficient (ICC).</p><p><strong>Results: </strong>Reproducibility was moderate (95% limits of agreement, -2.3 to 2.4 years; ICC 0.72; 95% confidence interval, 0.71-0.73). Both self-respondents (N = 6,664) and the total study population (N = 9,043) maintained moderate reproducibility even at older ages. Groups with proxy reports showed lower reproducibility than self-respondents, with spouse proxy reports showing highest reproducibility and parent proxy reports showing lowest reproducibility among proxy reports, although the comparisons are based on different survey ages in 1969.</p><p><strong>Conclusion: </strong>This is the first study to evaluate menarcheal-age reproducibility between self- and proxy-reports using appropriate measures. Mail questionnaires at 9-year interval showed moderate reproducibility across all ages, including elderly self-respondents. Reproducibility varied by the respondent-target relationship, with spouse proxies showing highest and parent proxies showing lowest reproducibility among proxy reports. Additional data are required to establish appropriate methods for handling specific proxy responses.</p>","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":"490-495"},"PeriodicalIF":3.0,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12527403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum for "Area Deprivation and Health Outcomes in Preschool Children in Japan: A Nationwide Cohort Study" [J Epidemiol 35(11) (2025) 472-481]. “区域剥夺与日本学龄前儿童健康结局:一项全国性队列研究”[J] .流行病学杂志(2025)doi:10.2188/ jej . je20240426。印刷前的Epub。
IF 3 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-05 Epub Date: 2025-09-30 DOI: 10.2188/jea.JE20250272
Naomi Matsumoto, Etsuji Suzuki, Soshi Takao, Tomoki Nakaya, Ichiro Kawachi, Takashi Yorifuji
{"title":"Erratum for \"Area Deprivation and Health Outcomes in Preschool Children in Japan: A Nationwide Cohort Study\" [J Epidemiol 35(11) (2025) 472-481].","authors":"Naomi Matsumoto, Etsuji Suzuki, Soshi Takao, Tomoki Nakaya, Ichiro Kawachi, Takashi Yorifuji","doi":"10.2188/jea.JE20250272","DOIUrl":"10.2188/jea.JE20250272","url":null,"abstract":"","PeriodicalId":15799,"journal":{"name":"Journal of Epidemiology","volume":" ","pages":"496-497"},"PeriodicalIF":3.0,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12527405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144775492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1